Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

AI and machine learning assisted development of greener formulations and pharmaceutical processes based on amorphous solid dispersions

Project description

Greener pharma solutions

The pharmaceutical industry faces challenges in reducing its environmental impact while maintaining efficiency and innovation. Supported by the Marie Skłodowska-Curie Actions programme, the i-GREENPHARM project addresses this pressing issue by uniting a diverse group of research and innovation organisations. By employing multidisciplinary technological approaches, the project aims to establish a proof-of-concept framework for greener pharmaceutical practices. Central to this initiative is the introduction of hot-melt extrusion as a novel production method, enhanced by AI and machine learning tools. The project will facilitate knowledge transfer around these core activities, supported by comprehensive environmental assessments, to foster sustainable practices within the pharmaceutical sector.

Objective

This proposal is bringing together R&I related staff by a complementary set of participating organisations that will use multidisciplinary technological approaches to provide a proof-of concept framework for designing and introducing greener practices in pharmaceuticals. Knowledge will be transferred around the core technical activity that will be the introduction of HME as a novel production method, based on AI-ML tools and supported by environmental assessment for greener pharmaceuticals.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
This project's classification has been human-validated.

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA Staff Exchanges

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-MSCA-2023-SE-01

See all projects funded under this call

Coordinator

ANFARM HELLAS AP NIKOLAOU PHARMACEUTICAL INDUSTRY SA
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 110 400,00
Address
ACHAIAS 4 & TRIZINIAS STR
14564 KIFISSIA
Greece

See on map

Region
Αττική Aττική Βόρειος Τομέας Αθηνών
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (5)

Partners (4)

My booklet 0 0